Manulife (Manufacturers Life Insurance)
ADMA icon

Manulife (Manufacturers Life Insurance)’s ADMA Biologics ADMA Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.03M Sell
114,512
-2,284
-2% -$36K ﹤0.01% 1818
2025
Q4 		$2.13M Sell
116,796
-4,980
-4% -$83.9K ﹤0.01% 1492
2025
Q3 		$1.79M Sell
121,776
-596
-0.5% -$10.2K ﹤0.01% 1570
2025
Q2 		$2.23M Sell
122,372
-2,854
-2% -$58.2K ﹤0.01% 1453
2025
Q1 		$2.48M Buy
125,226
+4,614
+4% +$79.8K ﹤0.01% 1407
2024
Q4 		$2.07M Sell
120,612
-6,105
-5% -$115K ﹤0.01% 1544
2024
Q3 		$2.53M Sell
126,717
-3,022
-2% -$47K ﹤0.01% 1473
2024
Q2 		$1.45M Buy
129,739
+18,977
+17% +$159K ﹤0.01% 1636
2024
Q1 		$731K Buy
110,762
+31,798
+40% +$174K ﹤0.01% 2032
2023
Q4 		$357K Sell
78,964
-1,784
-2% -$6.6K ﹤0.01% 2321
2023
Q3 		$289K Hold
80,748
– – ﹤0.01% 2392
2023
Q2 		$298K Buy
80,748
+11,933
+17% +$44.2K ﹤0.01% 2371
2023
Q1 		$228K Hold
68,815
– – ﹤0.01% 2475
2022
Q4 		$267K Sell
68,815
-3,015
-4% -$9.3K ﹤0.01% 2380
2022
Q3 		$175K Sell
71,830
-2,126
-3% -$5.1K ﹤0.01% 2643
2022
Q2 		$146K Buy
+73,956
New +$146K ﹤0.01% 2801
2021
Q1 		– Sell
-33,218
Closed -$865K – 3074
2020
Q4 		$865K Sell
33,218
-4,122
-11% -$8.66K ﹤0.01% 1901
2020
Q3 		$89K Hold
37,340
– – ﹤0.01% 2814
2020
Q2 		$110K Sell
37,340
-2,740
-7% -$7.87K ﹤0.01% 2724
2020
Q1 		$115K Buy
40,080
+8,908
+29% +$30.8K ﹤0.01% 2531
2019
Q4 		$125K Buy
31,172
+601
+2% +$2.62K ﹤0.01% 2739
2019
Q3 		$142K Buy
+30,571
New +$128K ﹤0.01% 2730

Other funds holding ADMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s ADMA Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its ADMA Biologics (ADMA) stake by 2% in Q1 2026, selling an estimated $36K and leaving 114,512 shares worth $1.03M. The position accounts for ﹤0.01% of the portfolio, ranked #1818.

Manulife (Manufacturers Life Insurance) first reported a position in ADMA in Q3 2019 and has held it in 22 quarters since. The position peaked at $2.53M in Q3 2024. 356 funds tracked by Wall St. Rank hold ADMA as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 114,512 shares of ADMA Biologics worth $1.03M as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) sold 2,284 ADMA Biologics shares in Q1 2026, an estimated $36K.
  • ADMA Biologics made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #1818 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in ADMA Biologics in Q3 2019 and has held it in 22 quarters since.
  • Manulife (Manufacturers Life Insurance)'s ADMA Biologics position peaked at $2.53M in Q3 2024.
  • 356 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.